ARGAX | MERFX | ARGAX / MERFX | |
Total Expense Ratio | 1.78 | 1.56 | 114% |
Annual Report Gross Expense Ratio | 1.78 | 1.67 | 107% |
Fund Existence | 12 years | 37 years | - |
Gain YTD | 5.132 | 5.834 | 88% |
Front Load | 3% | 6% | 50% |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 733M | 2.39B | 31% |
Annual Yield % from dividends | 0.45 | 1.65 | 28% |
Returns for 1 year | 5.14 | 5.24 | 98% |
Returns for 3 years | 7.56 | 9.20 | 82% |
Returns for 5 years | 3.97 | 10.48 | 38% |
Returns for 10 years | 8.32 | 24.85 | 33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.71 | 0.09 | +0.71% |
Saratoga Health & Biotechnology C | |||
GCINX | 15.50 | 0.06 | +0.39% |
Green Century MSCI Intl Indx Indvl Inv | |||
FCUEX | 20.32 | 0.03 | +0.15% |
NYLI PineStone U.S. Equity Class A | |||
OEGAX | 28.68 | -0.07 | -0.24% |
Invesco Discovery Mid Cap Growth A | |||
MUSBX | 36.64 | -0.13 | -0.35% |
MFS Blended Research Core Equity B |